These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

647 related items for PubMed ID: 15534123

  • 21. Pulse pressure lowering effect of dual blockade with candesartan and lisinopril vs. high-dose ACE inhibition in hypertensive type 2 diabetic subjects: a CALM II study post-hoc analysis.
    Knudsen ST, Andersen NH, Poulsen SH, Eiskjaer H, Hansen KW, Helleberg K, Poulsen PL, Mogensen CE.
    Am J Hypertens; 2008 Feb; 21(2):172-6. PubMed ID: 18188164
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Visual outcomes of pan-retinal photocoagulation in diabetic retinopathy at one-year follow-up and associated risk factors.
    Rema M, Sujatha P, Pradeepa R.
    Indian J Ophthalmol; 2005 Jun; 53(2):93-9. PubMed ID: 15976463
    [Abstract] [Full Text] [Related]

  • 26. Intravitreal bevacizumab (Avastin) prevention of panretinal photocoagulation-induced complications in patients with severe proliferative diabetic retinopathy.
    Mason JO, Yunker JJ, Vail R, McGwin G.
    Retina; 2008 Oct; 28(9):1319-24. PubMed ID: 18667958
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Medical management of diabetic retinopathy: an overview.
    Malek M, Khamseh ME, Aghili R, Emami Z, Najafi L, Baradaran HR.
    Arch Iran Med; 2012 Oct; 15(10):635-40. PubMed ID: 23020540
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Preventing blindness due to diabetic retinopathy. Control glycaemia and blood pressure, and monitor the eyes.
    Prescrire Int; 2010 Feb; 19(105):35-8. PubMed ID: 20455344
    [Abstract] [Full Text] [Related]

  • 33. Analysis of macular edema after cataract surgery in patients with diabetes using optical coherence tomography.
    Kim SJ, Equi R, Bressler NM.
    Ophthalmology; 2007 May; 114(5):881-9. PubMed ID: 17275910
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Prospects for angiotensin receptor blockers in diabetic retinopathy.
    Sjølie AK.
    Diabetes Res Clin Pract; 2007 May; 76 Suppl 1():S31-9. PubMed ID: 17321627
    [Abstract] [Full Text] [Related]

  • 36. The prevalence and severity of diabetic retinopathy, associated risk factors and vision loss in patients registered with type 2 diabetes in Luganville, Vanuatu.
    Smith TS, Szetu J, Bourne RR.
    Br J Ophthalmol; 2007 Apr; 91(4):415-9. PubMed ID: 17077115
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Current status of antihypertensive prescription and associated blood pressure control in Japan.
    Mori H, Ukai H, Yamamoto H, Saitou S, Hirao K, Yamauchi M, Umemura S.
    Hypertens Res; 2006 Mar; 29(3):143-51. PubMed ID: 16755149
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Effects of RAS inhibitors on diabetic retinopathy: a systematic review and meta-analysis.
    Wang B, Wang F, Zhang Y, Zhao SH, Zhao WJ, Yan SL, Wang YG.
    Lancet Diabetes Endocrinol; 2015 Apr; 3(4):263-74. PubMed ID: 25660574
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.